|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________
Form
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
|
(State or other jurisdiction | (Commission | (IRS Employer |
(Address of principal executive offices)
(Zip Code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report.)
Title of each class | Trading Symbol(s) | Name of exchange on which registered |
The |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01. Regulation FD Disclosure.
On May 10, 2021, AquaBounty Technologies, Inc. (the “Company”) issued a press release announcing that purchase orders have been received for the full output of the first commercial-scale harvest of its genetically engineered Atlantic salmon. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.
The information included in this Current Report on Form 8-K pursuant to Item 7.01, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit No. |
| Description |
| Press release issued by AquaBounty Technologies, Inc. on May 10, 2021, furnished herewith. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
| AquaBounty Technologies, Inc. |
|
| (Registrant) |
|
|
|
May 10, 2021 |
| /s/ David A. Frank |
|
| David A. Frank |
|
| Chief Financial Officer |
Exhibit 99.1
AquaBounty Sells Out the First Commercial-Scale Harvest
of Genetically Engineered Atlantic Salmon from its Indiana Farm
With end of May harvest, land-based aquaculture company is poised to provide a sustainable, secure, domestic source of farm-raised salmon
MAYNARD, Mass, May 10, 2021 — AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that purchase orders have been received for the planned harvest of 5 metric tons of its genetically engineered (GE) Atlantic salmon. The first harvest is scheduled to be conducted at the end of May from the Company’s Indiana farm. The Company will continue to ramp production to its full capacity throughout the year. AquaBounty is the first and only company in the world to raise and market a GE Atlantic salmon approved by the U.S. Food and Drug Administration (FDA) and Health Canada.
AquaBounty pioneered a sustainable and efficient way to meet today’s seafood demand using genetic engineering. The benefits of a one-time trait modification accomplished over three decades ago continue today through conventional breeding and spawning methods. The thirty-year journey to market included two decades of regulatory review culminating in FDA approval in 2015 and Health Canada approval in 2016.
AquaBounty’s GE Atlantic salmon reach harvest weight faster and more efficiently than Atlantic salmon grown in sea cages. Raised in land-based recirculating aquaculture systems (RAS) where the feeding cycle and growing environment are optimized, AquaBounty can produce up to 70 percent more fresh salmon annually compared to conventional Atlantic salmon grown in the same period under the same conditions. The benefit is a fresh, healthy protein that is produced more efficiently and feeds more people, which is good for consumers and the planet.
“I’m proud to see AquaBounty reach this important milestone using science and technology to provide sustainable seafood for a growing population,” said AquaBounty CEO Sylvia Wulf. “Our land-based aquaculture technology allows us to bring to market a healthy protein source. By raising our fish in freshwater from hatch to harvest, we offer an Atlantic salmon with a fresh, mild taste that consumers will enjoy.”
Raised in freshwater farms in America’s heartland in Albany, Indiana and in Rollo Bay, Prince Edward Island, Canada, AquaBounty’s salmon are free of antibiotics and ocean contaminants. Controlling the growing environment prevents exposure to parasites and pathogens that can lead to disease. AquaBounty’s fish swim and school naturally under the watchful eyes of carefully trained and experienced team members.
Wild salmon fisheries face increasing challenges to their habitat and their health. By locating salmon farming operations on land and following strict bio-security measures with multiple layers of containment that prevent escapes, AquaBounty helps protect wild salmon populations and native fisheries that are so important to Indigenous communities and others.
“The AquaBounty strategy for facility design and operation is driven by important considerations for the health of salmon,” said Wulf. “Our goal is to provide a delicious salmon that is produced in a secure and sustainable manner and raised right here in the United States.”
Customer and Culinary Support for AquaBounty Salmon:
“We have received very positive interest from a variety of customers representing seafood distributors, food service operators and retailers and are thrilled that the first harvest is already fully committed. It is gratifying to see that our customer partners understand the many benefits AquaBounty’s Atlantic salmon provide, and that they embrace technology that will bring more food to more people in a cost effective and sustainable manner,” said Wulf.
“AquaBounty’s sustainable land-based operations have a lower carbon footprint with reduced transportation requirements than Atlantic salmon that we import from other suppliers, and that’s exactly what this industry needs to feed a growing population,” said Joe Lasprogata, Vice President, New Product Development at Samuels and Son Seafood Co., a Philadelphia-based seafood distributor of AquaBounty’s Atlantic salmon. “AquaBounty’s genetically engineered salmon is a reliable and efficient source of salmon that is a product of the U.S.A., tastes delicious and looks great. We can’t wait to share this with our customers.”
Chef Charlie Baggs, from Charlie Baggs Culinary Innovations and serving as AquaBounty’s Executive Chef, commented, “AquaBounty’s salmon represents a critically important solution to meeting growing consumer demand and does so in a way that is sustainable. Their Atlantic salmon provides foodservice operators and retailers with salmon locally raised and harvested in the U.S.A, which is good for the environment and their customers. After tasting the product, the quality is excellent with firm texture, vibrant color and a clean taste. I believe these positive attributes will drive consumer purchases.”
About AquaBounty:
AquaBounty Technologies, Inc. (NASDAQ: AQB) is a leader in aquaculture leveraging decades of technology expertise to deliver game changing solutions that solve global problems, while improving efficiency, sustainability and profitability. AquaBounty provides fresh Atlantic salmon to nearby markets by raising its fish in carefully monitored land-based fish farms through a safe, secure and sustainable process. The Company’s land-based Recirculating Aquaculture System (“RAS”) farms, located in Indiana, United States and Prince Edward Island, Canada, are close to key consumption markets and are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. AquaBounty is raising nutritious salmon that is free of antibiotics and other contaminants and provides a solution resulting in a reduced carbon footprint and no risk of pollution to marine ecosystems as compared to traditional sea-cage farming. For more information on AquaBounty, please visit www.aquabounty.com or follow us on Facebook, Twitter, LinkedIn and Instagram.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. All statements other than statements of historical fact contained in this release are forward-looking statements, including, but not limited to, statements regarding purchase orders, commitments and prospective agreements with customers; anticipated growth in market size; anticipated productivity, the expected benefits of AquAdvantage salmon and land-based production to consumers and the environment, including consistency of supply, disease- and antibiotic-free production, resource conservation, and reduced carbon footprint; potential production capacity; and the size and timing of future harvests. Forward-looking statements may be identified with words such as “will,” “may,” “can,” “expect,” “plan,” “anticipate,” “upcoming,” “believe,” “estimate,” or similar terminology, and the negative of these terms. Forward-looking statements are not promises or guarantees of future performance and are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Forward-looking statements speak only as of the date hereof, and, except as required by law, we undertake no obligation to update or revise these forward-looking statements. For additional information regarding these and other risks faced by us, please refer to our public filings with the Securities and Exchange Commission (“SEC”), available on the Investors section of our website at www.aquabounty.com and on the SEC’s website at www.sec.gov.
MEDIA CONTACT:
John Curtis
Fahlgren Mortine
208-472-0595
john.curtis@fahlgren.com